Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yadi Yuan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Viruses|April 30, 2021
Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine EfficacyPei Liu, Yadi Yuan, Bopei Cui, et al.
Human Vaccines & Immunotherapeutics|August 5, 2020
A uniform quantitative enzyme-linked immunosorbent assay for Coxsackievirus A16 antigen in vaccineBopei Cui, Fang Cai, Fan Gao, et al.
Vaccine|March 1, 2022
Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccineFan Gao, Chaoqiang An, Lianlian Bian, et al.
Signal Transduction and Targeted Therapy|March 4, 2022
Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primatesQian He, Qunying Mao, Xiaozhong Peng, et al.
Frontiers in Immunology|September 5, 2022
Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaquesQian He, Qunying Mao, Jialu Zhang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Viruses|April 30, 2021
Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine EfficacyPei Liu, Yadi Yuan, Bopei Cui, et al.
Human Vaccines & Immunotherapeutics|August 5, 2020
A uniform quantitative enzyme-linked immunosorbent assay for Coxsackievirus A16 antigen in vaccineBopei Cui, Fang Cai, Fan Gao, et al.
Vaccine|March 1, 2022
Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccineFan Gao, Chaoqiang An, Lianlian Bian, et al.
Signal Transduction and Targeted Therapy|March 4, 2022
Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primatesQian He, Qunying Mao, Xiaozhong Peng, et al.
Frontiers in Immunology|September 5, 2022
Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaquesQian He, Qunying Mao, Jialu Zhang, et al.
Pageof 1